Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Bamlanivimab Emergency use authorization Experimental Antiviral Jan/21/2021 2 2
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/20/2021 73 14
Low Molecular Weight Heparin Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/07/2021 5 1
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Dec/17/2020 7 0
LV::SFL Potential treatment - pre-clinical evidence Experimental Vaccine Dec/16/2020 1 0
KFVPKQPNMIL Potential treatment - theoretical effect Natural product Antiviral Dec/11/2020 1 0
Hypericin Potential treatment - theoretical effect Natural product Antiviral Dec/08/2020 5 0
Cyanidin-3-O-glucoside Potential treatment - pre-clinical evidence Natural product Antiviral Dec/08/2020 2 0
Rutin Potential treatment - pre-clinical evidence Natural product Antiviral Dec/08/2020 5 0
mRNA-1273 Emergency use authorization Experimental Vaccine Dec/03/2020 4 0